Claude Discovers Novel CRISPR-like Enzyme System ART
Anthropic announced that Claude discovered ART, a CRISPR-like enzyme system in phage DNA, consisting of a reverse transcriptase, an unknown partner gene, and repeated DNA arrays. The discovery was made by 950 Claude agents analyzing 200,000+ reverse transcriptases over 21 hours. ART's function is not yet known, but its structure suggests potential gene editing capabilities.
Key insights
Claude Independently Discovered a New Enzyme System in Phage DNA
Anthropic reported that Claude identified a previously unnoticed enzyme system in phage DNA, named ART (Array-associated Reverse Transcriptase). It comprises a reverse transcriptase, an unknown partner gene, and evenly spaced repeated DNA arrays similar to CRISPR. The arrays are transcribed into distinct short RNAs, hinting at a programmable mechanism. The discovery was made by approximately 950 Claude agents running for 21 hours, consuming 210 million tokens, screening over 200,000 reverse transcriptases down to 20 candidates, and writing human-readable reports.
ART's Structure Resembles CRISPR and May Enable Gene Editing
ART's components—reverse transcriptase, partner gene, and repeated arrays—are characteristic of known systems that perform DNA cutting, copying, or pasting. CRISPR is the most famous example, and other similar systems are being developed into biotech tools. Anthropic acknowledges that ART's precise function is unknown, but its structural similarity suggests it could represent a new gene editing mechanism. CRISPR pioneer Feng Zhang commented that such arrays merit further study.
AI for Biology Is on an Exponential Trend Similar to Mathematics
Anthropic CEO Dario Amodei stated that AI performance in new intellectual domains often goes from weak to superhuman in a few years, citing mathematics as an example. He believes biology is on a similar trajectory. While biology requires experimentation, humans can collaborate with AI to perform experiments and iterate. The main difference is that biology needs wet lab work, but AI can accelerate the discovery phase, potentially increasing the number of promising candidates in the drug development pipeline.
Anthropic's Life Sciences Team Uses Claude for Genomic Mining
Anthropic formed a life sciences research team earlier this year, with a wet lab in the Bay Area handling BSL-1 and BSL-2 level research. The team uses publicly available Claude Science and Claude Code tools, meaning other labs could replicate the workflow. Anthropic is now soliciting research collaboration proposals from external scientists. The discovery process involved minimal human input: an initial prompt to search for interesting reverse transcriptases, then Claude agents did the rest.